OpenAlex
PricingAboutJobs
Log inGet started
Work

A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Psychopharmacology
DOI: 10.1097/jcp.0b013e318224864d
Authors: Arifulla Khan, Mark Joyce, Sarah Atkinson, Ivan Eggens, Irina Baldytcheva, Hans Eriksson
Institutions: Duke University, Northwest Clinical Research Center, Duke Medical Center, CNS Healthcare, VA Finger Lakes Healthcare System, AstraZeneca (Sweden), AstraZeneca (United States)
Language: English

Topic: Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Subfield: Experimental and Cognitive Psychology
Field: Psychology
Domain: Social Sciences
Keywords: generalized anxiety disorder, atypical antipsychotics, monotherapy, once-daily dosing, dose-response relationship, Hamilton Anxiety Rating Scale, Clinical Global Impression Scale, psychiatric adverse events, antipsychotic tolerability, remission, placebo response
SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, AstraZeneca
OpenAlex ID: W1965144024
FWCI: 5.994
Cites: 54
Cited by: 71
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security